Broadfin Capital’s Arcturus Therapeutics ARCT Stock Holding History

Broadfin Capital’s Portfolio ARCT Stock Details ARCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-173,806	Closed	-$1.39M	–	55
2017 Q1	$1.39M	Sell	173,806 -120,066	-41%	-$1.11M	0.17%	48
2016 Q4	$4.32M	Buy	293,872 +1,379	+0.5%	+$20.6K	0.48%	46
2016 Q3	$5.06M	Buy	292,493 +70,049	+31%	+$2.26M	0.45%	55
2016 Q2	$6.99M	Hold	222,444	–	–	0.68%	38
2016 Q1	$5.9M	Hold	222,444	–	–	0.57%	46
2015 Q4	$9.78M	Hold	222,444	–	–	0.6%	46
2015 Q3	$9.4M	Sell	222,444 -3,243	-1%	-$171K	0.52%	50
2015 Q2	$10.3M	Buy	225,687 +3,399	+2%	+$156K	0.56%	45
2015 Q1	$8.76M	Buy	+222,288	New	+$9.78M	0.68%	41

Other funds holding ARCT

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

California Public Employees Retirement System

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return